What do we need to make genetic biomarker-guided treatment for renal cell carcinoma a reality?

Pharmacogenomics. 2017 Jan;18(1):1-4. doi: 10.2217/pgs-2016-0168. Epub 2016 Dec 14.
No abstract available

Keywords: SNP; biomarker; pharmacogenetics; renal cell carcinoma; targeted therapy.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / genetics
  • Drug Monitoring
  • Genetic Markers
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / genetics
  • Molecular Targeted Therapy / methods*
  • Polymorphism, Single Nucleotide*

Substances

  • Antineoplastic Agents
  • Genetic Markers